Singapore  Singapore

Post Ad
Listing Id: 32476 Last Refreshed: 30/07/2024 Total Views: 594

(Expired)Entry Investment Into Australian Pharmaceuticals

Boon LayMedical SupplyOnline Shops
Asking Price: Price On Request
Business For Takeover
Look For Investor
Look For Partner
David Walker

Businesses Viewed

Recommended Businesses

  • Overview
  • Reason For Sale
  • Description
  • Property Information

Overview

  • Premise Type Office Building
  • Premise Size N/A
  • Monthly Rental N/A
  • Rental Desposit N/A
  • Revenue N/A
  • Liability N/A
  • Gross Profit N/A
  • Net Profit N/A
  • Stock N/A
  • FFE N/A
  • Payable N/A
  • Receivable N/A
  • Owner Role Full Time
  • Staff 7
  • Established 2023
  • Source Direct Seller

Reason For Sale

Selling shares in company to raise funds for expansion

Description

I have a life changing opportunity for a savvy investor to invest in an Australian Pharmaceutical company in its infancy, getting in early means you can enjoy exponential growth in your investment at a low entry cost.

AtheroCare Australia has exclusive rights in Australia to supply the groundbreaking heart and artery health supplement Cavadex. With everything set up perfectly for steady growth into the future we are facing an issue; Cavadex is in the process of publishing a journal paper that would see sales sky rocket, we will need capital to ramp up operations for the sudden increase in demand for the product.

For the first time since inception AtheroCare Australia is offering up to 400,000 shares at AUD$2.65 per share with a minimum investment of 5,000 shares at AUD$13,250 per share holder.

Please see the investor brief and visit our website www.atherocare.com for more information.

I look forward to partnering with you in this venture.

Thank you
David Walker

www.atherocare.com
david@atherocare.com

Property Information

Rent
Premise Status
/

Just a moment... we are processing the request